Patents by Inventor Kevin R. Stone

Kevin R. Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10368856
    Abstract: A flexible member for coupling tissue. The flexible member includes a tail and a self-locking construct. The tail includes a first end and a second end opposite to the first end. The tail defines a tail passageway proximate to the second end. The self-locking construct includes a first loop and an adjustable second loop. The second loop is slidably threaded through the tail passageway defined by the tail. The self-locking construct is configured such that passing the tail through the first loop so that the second loop extends into the first loop forms a tissue capture region defined by the self-locking construct. The tail passageway defined by the tail defines a locking member configured to secure the second loop to the first loop.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: August 6, 2019
    Assignee: Biomet Sports Medicine, LLC
    Inventors: Kevin T. Stone, Gregory J. Denham, Daniel R Norton
  • Publication number: 20190150923
    Abstract: A soft tissue repair device can include a housing having a handle, a deployment system having an actuation member, and an insertion system having an inserter and a slider. The slider can be coupled to the actuation member and movable relative to the inserter between deployed and retracted positions. First and second anchors can be carried on an external surface of the slider such that the anchors are spaced apart and portions of the anchors are coaxial with the slider and each other. A flexible strand can couple the anchors. The insertion system can cooperate with the deployment system to move the slider to the deployed position to deploy the first anchor upon activating the actuation member a first time, and to move the slider to the deployed position from the retracted position to deploy the second anchor upon actuating the actuation member a second time after the first time.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 23, 2019
    Inventors: Kevin T. Stone, Nathan M. Sautter, Brian K. Berelsman, Jeffery D. Arnett, Joshua A. Butters, Dylan M. Hushka, Nicholas R. Slater
  • Patent number: 8567561
    Abstract: The invention presents devices for controlled descent from buildings. Such a device includes a housing having a primary spool about which a cord is wound, a payload coupler for attaching a harness assembly to the housing, and an unwind control assembly for controlling the rate of exit of the cord from the housing. An inventive device kit may include a convertible storage unit used to protectively store a device and which, upon deployment, may be used as a protective helmet. In using an inventive device, a user attaches the device to a fixture in a building, dons a harness and the converted helmet, attaches the device to the harness, and exits the building from a window or roof.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: October 29, 2013
    Assignee: Rescue Reel, LLC
    Inventors: Michael Strasser, Thomas King, Kevin R. Stone
  • Patent number: 8499890
    Abstract: A personal escape device which can be used by men, women, and children, including physically disabled persons, to descend in a controlled and secure manner from high structures such as office buildings, multistory homes, and the like. The device is designed for a relatively low-cost, small size which may be used by payloads of variable weights. The rescue device of the invention may be a single-use device or a multi-use device.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: August 6, 2013
    Assignee: Rescue Reel, LLC
    Inventors: Kevin R. Stone, Michael Strasser, Thomas King, Imraan Aziz
  • Publication number: 20120207718
    Abstract: An articular cartilage shell graft is designed to treat the arthritic population for which current biologic treatments are insufficient and as a biological-stage repair for intervention before prosthetic knee arthroplasty.
    Type: Application
    Filed: February 15, 2012
    Publication date: August 16, 2012
    Inventors: KEVIN R. STONE, THOMAS J. TUREK
  • Publication number: 20110104229
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic bone xenograft (X) for the implantation into a defect (D) located in a bone portion (10) of a human. The invention further provides methods for preparing a bone xenograft (X) by removing at least a portion of bone from a non-human animal to provide a xenograft (X); washing the xenograft (X) in saline and alcohol; and subjecting the xenograft (X) to at least one of the treatments including exposure to ultraviolet radiation, immersion in alcohol, ozonic, and freeze/thaw cycling. In addition to or in lieu of the above treatments, the methods include a cellular disruption treatment, and digestion of the carbohydrate moieties of the xenograft (X) with a glycosidase followed by treatment for sialylation.
    Type: Application
    Filed: October 21, 2010
    Publication date: May 5, 2011
    Inventors: Kevin R. Stone, Uri Galili
  • Patent number: 7851458
    Abstract: A food supplement, either in the form of a snack bar or a beverage, which contains one or more cartilage enhancing supplements is provided. The cartilage supplements include chondroitin, glucosamine, and hyaluronic acid. The food supplement may additionally be fortified with cetyl myristoleate. The beverage is a mixture of a juice drink base which may include a water-based fruit flavored juice prepared using a pasteurization process at a relatively high temperature and a cartilage supplement solution which includes a cartilage supplement prepared at a relatively low temperature. The beverage may be carbonated, non-carbonated or concentrated. The preferred cartilage supplement is glucosamine, preferably associated with a counter ion, more preferably as glucosamine HCl. The supplement also contains vitamin C (ascorbic acid) and calcium hydroxide powder.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: December 14, 2010
    Assignee: Joint Juice, Inc.
    Inventor: Kevin R. Stone
  • Publication number: 20100196499
    Abstract: The invention provides for the use of an improved xenograft bone particulate with respect to osteo-integration and bone remodeling, while diminishing the primate-to-pig immunological response using established bone-processing technique. Work was carried out using undecalcified bone to determine immunocompatibilty and bone remodeling potential of processed porcine bone struts following onlay graft implantation. New bone formation was evident, including the infiltration of cellular materials responsible for fusion and bone reconstruction.
    Type: Application
    Filed: September 3, 2009
    Publication date: August 5, 2010
    Inventors: Kevin R. Stone, Thomas J. Turek
  • Publication number: 20100196870
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic xenograft for implantation into humans. The invention also provides methods for preparing a xenograft by removing at least a portion of a soft tissue from a non-human animal to provide a xenograft; washing the xenograft in saline and alcohol; subjecting the xenograft to cellular disruption treatment; treating the xenograft with crosslinking agents, and digesting the xenograft with a proteoglycan-depleting factor and/or glycosidase. The invention further provides a method for sterilizing xenograft material, having the steps of obtaining substantially non-immunogenic xenograft material; treating the xenograft material with at least one crosslinking agent; and subjecting the crosslinked xenograft material to radiation treatment.
    Type: Application
    Filed: September 3, 2009
    Publication date: August 5, 2010
    Inventors: Kevin R. Stone, Thomas J. Turek
  • Publication number: 20100163343
    Abstract: A personal escape device which can be used by men, women, and children, including physically disabled persons, to descend in a controlled and secure manner from high structures such as office buildings, multistory homes, and the like. The device is designed for a relatively low-cost, small size which may be used by payloads of variable weights. The rescue device of the invention may be a single-use device or a multi-use device.
    Type: Application
    Filed: January 15, 2010
    Publication date: July 1, 2010
    Applicant: STONE'S THROW
    Inventors: KEVIN R. STONE, Michael Strasser, Thomas King, Imraan Aziz
  • Patent number: 7722672
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic bone xenograft for implantation into humans. The invention further provides a method for preparing a bone xenograft by removing at least a portion of a bone from a non-human animal to provide a xenograft (X); washing the xenograft in saline and alcohol; subjecting the xenograft to a cellular disruption treatment; and treating the xenograft with a glycosidase to remove surface carbohydrate moieties. The invention also provides an article of manufacture produced by the above identified method of invention. The invention further provides a bone xenograft for implantation into a human including a portion (10) of a bone from a nonhuman animal, wherein the portion has substantially no surface carbohydrate moieties which are susceptible to glycosidase digestion. Each xenograft of the invention has substantially the same mechanical properties as a corresponding native bone.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: May 25, 2010
    Inventor: Kevin R. Stone
  • Publication number: 20100065373
    Abstract: The invention presents devices for controlled descent from buildings. Such a device includes a housing having a primary spool about which a cord is wound, a payload coupler for attaching a harness assembly to the housing, and an unwind control assembly for controlling the rate of exit of the cord from the housing. An inventive device kit may include a convertible storage unit used to protectively store a device and which, upon deployment, may be used as a protective helmet. In using an inventive device, a user attaches the device to a fixture in a building, dons a harness and the converted helmet, attaches the device to the harness, and exits the building from a window or roof.
    Type: Application
    Filed: July 18, 2008
    Publication date: March 18, 2010
    Inventors: Kevin R. Stone, Michael Strasser, Thomas King
  • Patent number: 7645568
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic heart valve xenograft for implantation into humans. The invention further provides methods for preparing a heart valve xenograft by removing at least a portion of a soft tissue from a non-human animal to provide a xenograft; washing the xenograft in saline and alcohol; subjecting the xenograft to cellular disruption treatment; treating the xenograft with crosslinking agents, and digesting the xenograft with a proteoglycan-depleting factor and/or glycosidase. The invention also provides an article of manufacture produced by the above-identified method of the invention. The invention further provides a heart valve xenograft for implantation into a human including a portion of a heart valve from a non-human animal, wherein the portion has extracellular components and substantially only dead cells. The extracellular components have reduced proteoglycan molecules.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: January 12, 2010
    Assignee: Aperion Biologics, Inc.
    Inventor: Kevin R. Stone
  • Patent number: 7595377
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic injectable collagen for implantation into humans. The invention further provides methods for preparing injectable collagen material by removing collagen-containing material from a non-human animal; washing in saline and alcohol; subjecting material to cellular disruption treatment; and digesting the material with a proteoglycan-depleting factor and/or glycosidase and optionally following with a capping treatment. The invention also provides an article of manufacture produced by the method. The injectable collagen material of the invention are substantially non-immunogenic and have substantially the same mechanical properties as a corresponding native soft tissue.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: September 29, 2009
    Assignee: Crosscart, Inc.
    Inventor: Kevin R. Stone
  • Patent number: 7594934
    Abstract: Matrix material for a substantially immunologically-compatible meniscal augmentation device of biocompatible and partially bioresorbable fibers is prepared by treatment with oc-galactosidase to eliminate oc-Gal epitopes. Upon implantation into a segmental defect of a meniscus, the composite of the meniscal augmentation device and the meniscus establishes a scaffold adapted for ingrowth of meniscal fibrochondrocytes.
    Type: Grant
    Filed: June 4, 2003
    Date of Patent: September 29, 2009
    Assignee: Crosscart, Inc.
    Inventor: Kevin R. Stone
  • Publication number: 20090030517
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic bone xenograft (X) for implantation into a defect (D) located in a bone portion (10) of a human. The invention further provides methods for preparing a bone xenograft (X) by removing at least a portion of bone from a non-human animal to provide a xenograft (X); washing the xenograft (X) in saline and alcohol; and subjecting the xenograft (X) to at least one of the treatments including exposure to ultraviolet radiation, immersion in alcohol, ozonic, and freeze/thaw cycling. In addition to or in lieu of the above treatments, the methods include a cellular disruption treatment, and digestion of the carbohydrate moieties of the xenograft (X) with a glycosidase followed by treatment for sialylation.
    Type: Application
    Filed: March 17, 2008
    Publication date: January 29, 2009
    Inventors: Kevin R. Stone, Uri Galili
  • Patent number: 7064187
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic injectable collagen for implantation into humans. The invention further provides methods for preparing injectable collagen material by removing collagen-containing material from a non-human animal; washing in saline and alcohol; subjecting material to cellular disruption treatment; and digesting the material with a proteoglycan-depleting factor and/or glycosidase and optionally following with a capping treatment. The invention also provides an article of manufacture produced by the method. The injectable collagen material of the invention are substantially non-immunogenic and have substantially the same mechanical properties as a corresponding native soft tissue.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: June 20, 2006
    Assignee: CrossCart, Inc.
    Inventor: Kevin R. Stone
  • Patent number: 6972041
    Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic bone xenograft for implantation into humans. The invention further provides a method for preparing a bone xenograft by removing at least a portion of a bone from a non-human animal to provide a xenograft (X); washing the xenograft in saline and alcohol; subjecting the xenograft to a cellular disruption treatment; and treating the xenograft with a glycosidase to remove surface carbohydrate moieties. The invention also provides an article of manufacture produced by the above identified method of invention. The invention further provides a bone xenograft for implantation into a human including a portion (10) of a bone from a nonhuman animal, wherein the portion has substantially no surface carbohydrate moieties which are susceptible to glycosidase digestion. Each xenograft of the invention has substantially the same mechanical properties as a corresponding native bone.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: December 6, 2005
    Assignee: CrossCart, Inc.
    Inventor: Kevin R. Stone
  • Publication number: 20040243250
    Abstract: A method for preparing a soft tissue xenograft includes the steps of removing at least a portion of a soft tissue from a non-human animal to provide a xenograft; washing the xenograft in saline and alcohol: subjecting the xenograft to cellular disruption treatment; and either digesting the xenograft with a glycosidase or glycosidase digestion followed by treatment for sialylation. A soft tissue xenograft for implantation into a human includes a portion of a soft tissue from a non-human animal, wherein the portion has extracellular matrix and substantially only dead cells. The matrix and dead cells have substantially no surface &agr;-galactosyl moieties and have sialic acid molecules linked to at least a portion of surface carbohydrate moieties. Each of the xenografts of the invention has substantially the same mechanical properties as a corresponding native soft tissue.
    Type: Application
    Filed: July 2, 2004
    Publication date: December 2, 2004
    Inventors: Kevin R. Stone, Uri Galili
  • Publication number: 20040234507
    Abstract: The invention provides a substantially non-immunogenic submucosal xenograft for implantation into humans. The invention further provides methods for preparing the xenograft by removing at least a portion of a submucosa from a non-human animal; washing the xenograft in saline and alcohol; subjecting the xenograft to cellular disruption treatment; and digesting the xenograft with a glycosidase to remove surface carbohydrate moieties. The invention also provides an article of manufacture produced by the above-identified method. The invention further provides a submucosal xenograft for implantation into a human including a portion of a submucosal tissue from a non-human animal, wherein the portion has substantially no surface carbohydrate moieties that are susceptible to glycosidase digestion. Each of the xenografts has substantially the same mechanical properties as native soft tissue.
    Type: Application
    Filed: June 25, 2004
    Publication date: November 25, 2004
    Inventor: Kevin R Stone